ABCG2 reduces ROS-mediated toxicity and inflammation: a potential role in Alzheimer's disease

Journal of Neurochemistry
Shanshan ShenWandong Zhang

Abstract

Alzheimer's disease is characterized by accumulation and deposition of Aβ peptides in the brain. Aβ deposition generates reactive-oxygen species (ROS), which are involved in Alzheimer's inflammatory and neurodegenerative pathology. We have previously observed that, in Alzheimer's disease brain, ABCG2 is up-regulated and AP-1 is activated, but NF-κB is not activated. In the present study, we examine the roles and mechanism of ABCG2 on ROS generation, inflammatory gene expression and signaling, heme homeostasis and Aβ production in cell models and on inflammatory signaling and Aβ deposition in Abcg2-knockout and wild-type mice. Our results show that ABCG2 plays a protective role against oxidative stress by decreasing ROS generation, enhancing antioxidant capacity, regulating heme level, and inhibiting inflammatory response in cell models. ABCG2 inhibits NF-κB activation but has less effect on AP-1 activation induced by ROS. This results in inhibition of interleukin-8 and growth-related oncogene (GRO) expression induced by ROS via NF-κB pathway. Abcg2 deficiency increased Aβ deposition and NF-κB activation in the brains of Abcg2-knockout mice compared with controls. These findings suggest that ABCG2 may relieve oxidative stress an...Continue Reading

References

Oct 28, 1988·Science·P A Baeuerle, D Baltimore
Apr 1, 1997·Current Opinion in Cell Biology·M KarinE Zandi
Apr 1, 1997·Trends in Neurosciences·J Hardy
Sep 2, 1997·Proceedings of the National Academy of Sciences of the United States of America·M A SmithG Perry
Jul 17, 1998·Journal of the Neurological Sciences·M A LovellW R Markesbery
Dec 16, 1998·Journal of Neural Transmission. Supplementum·W RetzP Riederer
Jun 3, 2000·Annual Review of Immunology·M Karin, Y Ben-Neriah
Oct 18, 2000·Free Radical Biology & Medicine·E Cadenas, K J Davies
Feb 22, 2001·Free Radical Biology & Medicine·C A RottkampM A Smith
Mar 22, 2001·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·S WalpenJ Pfeilschifter
Sep 6, 2002·Journal of Alzheimer's Disease : JAD·J.R. ConnorM. Chorney
Nov 6, 2002·Proceedings of the National Academy of Sciences of the United States of America·Hani AtamnaBruce N Ames
Nov 14, 2002·Proceedings of the National Academy of Sciences of the United States of America·Johan W JonkerAlfred H Schinkel
Jun 11, 2003·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Kenneth R WagnerJoseph F Clark
Sep 6, 2003·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Wandong ZhangDanica B Stanimirovic
Feb 3, 2004·Current Pharmaceutical Design·Wieland GsellPeter Riederer
Mar 27, 2004·The Journal of Biological Chemistry·Partha KrishnamurthyJohn D Schuetz
Apr 1, 2004·Brain Research·Xiongwei ZhuGeorge Perry
Jul 13, 2004·Annals of the New York Academy of Sciences·David W KillileaBruce N Ames
Jul 21, 2004·Proceedings of the National Academy of Sciences of the United States of America·Hani Atamna, William H Frey
Mar 16, 2005·The Journal of Biological Chemistry·Kazuhiro HondaGeorge Perry
Dec 27, 2005·Current Topics in Medicinal Chemistry·Aurn K GhoshJordan Tang
Feb 24, 2006·Proceedings of the National Academy of Sciences of the United States of America·Hani Atamna, Kathleen Boyle
Jun 14, 2006·Neurobiology of Aging·Roberta Borghi Massimo Tabaton
Nov 23, 2006·Journal of Alzheimer's Disease : JAD·Hani Atamna
Dec 13, 2006·Neurobiology of Aging·Rodney T PerryWilliam D Hill
Dec 28, 2006·Neurochemical Research·Vittorio CalabreseAnnamaria Giuffrida Stella
Mar 21, 2007·Pharmacology & Therapeutics·Partha KrishnamurthyJohn D Schuetz
Apr 25, 2007·Journal of Neuroscience Research·Akanksha ThakurXiongwei Zhu
May 1, 2007·Biochemical Pharmacology·Catherine VerhaegheVincent Bours
Feb 7, 2009·Journal of Neurochemistry·Michela GuglielmottoMassimo Tabaton

❮ Previous
Next ❯

Citations

Aug 29, 2013·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Benoit HostenNicolas Tournier
Nov 28, 2012·ACS Chemical Neuroscience·Alaa H Abuznait, Amal Kaddoumi
Dec 15, 2015·Cardiovascular Toxicology·G S AjithkumarC C Kartha
Jun 8, 2011·Journal of Veterinary Pharmacology and Therapeutics·K L Mealey
Jun 13, 2015·Oxidative Medicine and Cellular Longevity·Ilaria DandoMarta Palmieri
Feb 6, 2018·European Journal of Pediatrics·Ana Savić MlakarKrešo Bendelja
Nov 25, 2017·Journal of Alzheimer's Disease : JAD·Cátia D PereiraSandra Rebelo
Jan 5, 2011·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·María Elena CarteaPablo Velasco
Apr 13, 2019·Current Topics in Medicinal Chemistry·Niraj Kumar JhaRituraj Niranjan
Nov 20, 2019·Journal of Clinical Medicine·Veronika HorváthováBlanka Stibůrková
Oct 26, 2018·Frontiers in Neuroscience·Deborah ChiabrandoEmanuela Tolosano
Feb 27, 2020·International Journal of Molecular Sciences·Yu-Chia KaoKuen-Jer Tsai
Jan 6, 2021·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Ravi K NarangNicola Dalbeth
Oct 23, 2019·Photodiagnosis and Photodynamic Therapy·M Ibrahim KhotDavid G Jayne
Apr 23, 2020·Pharmacology & Therapeutics·Eva Gil-MartinsRenata Silva
Mar 9, 2021·Seminars in Nephrology·Ravi K Narang, Nicola Dalbeth
Aug 21, 2021·Essays in Biochemistry·Jared S Katzeff, Woojin Scott Kim

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.